key: cord-0880703-ygasdp6s
authors: Sun, Jia; Chen, Luo; Xiao, Xiao-Ao; Jia, Mo-Qiu; Wang, Xin-Yuan; Jiao, Han; Gao, Yuanqing
title: Intestinal Expression of ACE2 in Mice with High-Fat Diet-Induced Obesity and Neonates Exposed to Maternal High-Fat Diet
date: 2021-03-07
journal: Nutrition
DOI: 10.1016/j.nut.2021.111226
sha: c393b823191a728f32a0ebfc1d1df955e60c53e5
doc_id: 880703
cord_uid: ygasdp6s

OBJECTIVE: The 2019 novel coronavirus disease (COVID-19) is threatening global health and is especially pronounced in patients with chronic metabolic syndromes. Meanwhile, a significant proportion of patients present with digestive symptoms since angiotensin-converting enzyme 2 (ACE2), which is the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),is highly expressed in the intestine. In this study, we evaluated the impact of a high-fat diet (HFD) and maternal HFD on the intestinal ACE2 levels in adults and neonates. METHODS: We examined intestinal ACE2 protein levels in mice with diet-induced obesity(DIO) and neonatal mice exposed to a maternal high-fat diet. We also investigated Ace2 mRNA expression in intestinal macrophages. RESULTS: Intestinal ACE2 protein levels were increased in DIO mice but decreased in offspring exposed to maternal HFD compared with chow-fed controls. Ace2 mRNA expression in intestinal macrophages was detected and downregulated in DIO mice. In addition, higher intestinal ACE2 protein levels were observed in neonates than in adult mice. CONCLUSIONS: The influence of a HFD on intestinal ACE2 protein levels is opposite in adults and neonates. Macrophages might also be involved in SARS-CoV-2 intestinal infection. These findings provide some clues for the outcomes of patients with COVID-19 with metabolic syndromes.

The 2019 novel coronavirus disease , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is prevalent worldwide (1) . In patients with infection, gastrointestinal reactions are very commonly reported, and SARS-CoV-2 RNA has been detected in feces and gastrointestinal tissues (2, 3) , indicating the existence of gastrointestinal infections and fecal-oral transmission. Accumulating evidence indicates that subjects with metabolic diseases experience more severe outcomes from COVID-19 (4, 5) .

Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for SARS-CoV-2 (6) and, according to the Human Protein Atlas database, is highly expressed in the gastrointestinal tract (7) . Exploring the factors affecting the expression of intestinal ACE2 may predict the outcomes of intestinal infection with SARS-CoV-2. It has been reported that ACE2 levels in adipose tissue are upregulated in obese/diabetic states (8, 9) . It is thus far unclear whether metabolic disorders may alter the expression of ACE2 in the intestine. We undertook this study to investigate the alteration of intestinal ACE2 expression in mice fed short-and long-term HFD as well as pups exposed to maternal HFD.

Recent studies have reported that SARS-CoV-2 can directly attack immune cells. In the lungs, ACE2-positive alveolar macrophages can be infected by SARS-CoV-2(10). Intestinal macrophages also play an important role in gut homeostasis; however, most intestinal studies in COVID-19 focus on epithelial cells, and it is unclear whether intestinal macrophages express ACE2 and contribute to gastrointestinal infection. Here, we also sought to determine whether intestinal macrophages may express ACE2 and whether it is altered in diet-induced obesity.

C57BL/6 mice were obtained from the Animal Core Facility of Nanjing Medical University and group housed under a 12-hour light/dark cycle at 23 °C with ad libitum access to food and water.

For HFD study, male mice were kept on a normal chowdiet(XietongShengwu, 1010013) till 8 weeks old, then fed on either a chow diet or a high-fat diet(58%HFD with sucrose, Research Diets D12331) for 12 weeks and 48 weeks. For maternal HFD study, 8-week old female mice were exposed to either a normal chow diet or a HFD for 12 weeks. A normal chow diet fed male mouse was added to each cage for breeding and they remained in the cages either with chow diet or HFD. Resulting male offspring were sacrificed at postnatal day 12(P12). All the animal experiments were approved by the Committee on Animal Care of Nanjing Medical University, and complied with National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.

Intestinal macrophages and microglia were isolated as described by us and others with minor modifications(11, 12). For intestinal macrophages, mice were euthanized, and the intestine was carefully removed, cut longitudinally, and cleaned in Hank's balanced salt solution(HBSS). Tissues were cut into pieces and washed twice in RPMI-1640 medium(Gibco, 22400089) supplemented with 5% fetal bovine serum(Gibco, 10091148) and 5mM EDTA at 37°C and shaked for 20min to remove epithelial cells. Tissue were then digested in accutase solution(Milipore, SCR005) for 40min, and passed through a 70-µm filter. For microglia, brains were homogenized in RPMI-1640 medium. Resuspended brain and gut lysates were layered on a 30%/70% (v/v) Percoll gradient and centrifuged without a brake at 500g for 30min. The mononuclear cells were collected from the gradient interface. After 30min incubation, the non-adherent dead cells and lymphocytes were washed away with HBSS. Attached live cells were harvested for ACE2 expression analysis and immunofluorescent staining.

The ileum and colon were dissected and rinsed in PBS to remove lumenal content. Tissues were lysed in RIPA buffer (Beyotime, P0013B) supplemented with cocktail protease inhibitor (1:100, Thermo Fisher Scientific, 87785). 30ug proteins were separated on 10% SDS-PAGE gel, and transferred onto nitrocellulose membranes (Millipore, HVHP09050). The membranes were blocked with 5% milk (PHYGENE, PH1519) for 1 h at room temperature, then incubated with the following primary antibodies overnight at 4°C: anti-ACE2 (1:1000, R&D Systems), anti-GAPDH (1:5000, Affinity Biosciences) and anti β-actin antibody (1:500, Santa Cruz).

Total RNA was extracted from primary cells or gut tissues using Trizol reagent (Invitrogen, 15596018) and subjected to reverse transcription with HiScript-II-Q RT SuperMix for qPCR (Vazyme, Q221-01). Real-time qPCR was carried out using SYBR Green Master Mix(Vazyme,Q131-02) on QuantStudio 5 (Applied Biosystems). The qPCR reaction was carried out according to the following conditions: pre-denaturation 5min at 95°C, 95°C 10sec followed by 60°C 30sec for 40 cycles, melting curve stage 95°C 15sec -60°C 60sec -95°C 15sec.

The following primers were used: Ace2: 5'-CTGGGCAGAAGTTGCTCAAG-3'(forward) and 5'-TGGGCTCCATTCAGTGTTCC-3'(reverse); β-actin:5'-CGCAGCCACTGTCGAGTC-3' (forward) and 5'-GTCATCCATGGCGAACTGGT-3'(reverse). Equal volume of qPCR products were subjected to 2% agarose gel electrophoresis to confirm the products sizes.

The intestines were fixed by 4% PFA 48h and dehydrated by 30% sucrose solution, and then embedded with OCT (SAKURA). 8 µm cyro sections were cut by cryostat microtome and sticked to the pre-coated glass slides. Cyro sections of the ileum and colon were incubated with anti-ACE2 antibody (1:1000, R&D Systems) overnight at 4°C.Sections were then incubated with biotin-conjugated secondary antibody for 1 h at room temperature, followed by avidin-biotin-HRP complex. The reaction was visualized by 1% diaminobenzidine with 0.01% hydrogen peroxide and then counterstained with hematoxylin. Air dried sections were further dehydrated in alcohol gradient and 100% xylene. Isolated intestinal macrophages on coverslips were fixed with 4% paraformaldehyde, washed and incubated with anti-iba1 antibody (1:800, Wako) overnight at 4°C, followed by 594 Alexa secondary antibody and mounted with anti-fading mounting medium with DAPI. Stained sections and cells were imaged with a fluorescence microscope (Nikon).

Data analysis and plots were performed using Prism 8.0 (GraphPad Software). Two groups were compared using a two-tailed unpaired student's t test. P value<0.05 was considered to indicate statistical significance. All data are shown as mean values ± SD.

We first characterized the expression of ACE2 in the gut of mice fed short-term (12 weeks) and long-term (48 weeks) HFD. Both 12-and 48-week HFD-fed mice gained significant body weight, and 48-week HFD-fed mice had hyperglycemia (Fig. 1A&B) . The ileum and colon of mice were analyzed for relative ACE2 expression at both mRNA and protein level. QPCR shows that Ace2 mRNA expressions are much higher in the ileum than colon as literature reported, however, there is no difference between Chow fed group and HFD fed group at both time points (Fig. 1C&D) .

Protein levels of ACE2 were anaylzed by western blot. Consistent with the HPA database and qPCR results, we observed that ACE2 is highly expressed in the ileum and is expressed at low levels in the colon, suggesting that the small intestine could be more prone to infection by COVID-19. Notably, ACE2 protein levels were much higher in the ileum of the HFD groups at both 12 and 48 weeks (Fig. 1E-H) . Compared with 12-week HFD feeding, ACE2 protein levels in the ileum were not further elevated by 48-week HFD feeding. In the colon, ACE2 protein levels were not different between the Chow and HFD groups. The higher surface protein level of ACE2 in the ileum of mice fed a 48-week HFD was confirmed by immunohistochemistry ( Fig. 1I-J) . These results show that ACE2 is highly expressed in the ileum and upregulated in DIO mice but is not further increased by age or prolonged HFD feeding.

It has been reported that alveolar macrophages and Kupfer cells express high levels of ACE2 and therefore could be targeted by SARS-CoV-2 (13) . Considering that little attention has been given to intestinal macrophages, we then sought to determine whether intestinal macrophages may express ACE2 and could be modulated in a diet-induced obesity model. The purity of isolated intestinal macrophages was 98.141.4%, as indicated by the ratio of Iba1 and DAPI counts( Fig.   2A) . ACE2 gene expression in intestinal macrophages was confirmed by RT-qPCR and the visualization of qPCR products on agarose gels (Fig. 2C) . Total RNA extracted from a piece of small intestine was used as the positive control. Meanwhile, in another type of tissue resident macrophage, microglia in the brain, ACE2 gene expression was undetectable (Fig. 2B&C) , suggesting that ACE2 is diversely distributed in macrophages in different organs. We next checked Ace2 mRNA expression in intestinal macrophages isolated from mice fed a HFD or chow diet. Unexpectedly, the Ace2 mRNA level was significantly decreased in intestinal macrophages of mice fed a HFD for 48 weeks (Fig. 2D) , which was opposite to the increased ACE2 expression in the whole tissue of the ileum. These results suggest that intestinal macrophages may take part in the pathological process of COVID-19, but the potential mechanisms need further study.

Considering that an increasing number of women have metabolic syndromes in their child-bearing period and that there are some cases of SARS-CoV-2 infection in newborns, we next evaluated the impact of maternal HFD on neonatal intestinal ACE2 expression. Surprisingly, on postnatal day 12, in the ileum of the male offspring exposed to maternal HFD, ACE2 mRNA levels and protein levels were both significantly decreased compared with that in the maternal chow-fed group (Fig. 3A-C) , which was opposite to the results in the adult DIO mice (Fig. 1E-H) .

Immunohistochemistry also confirmed the decreased ACE2 surface protein levels in the intestinal epithelium of neonatal mice exposed to maternal HFD (Fig. 3D&E) . Additionally, we compared intestinal ACE2 protein levels at different ages in chow-fed mice. The highest expression of intestinal ACE2 protein was detected in neonates compared with 20-and 56-week-old mice (Fig.   3F&G ). Taken together, these results suggest that neonates with high levels of intestinal ACE2 have a high risk of inducing SARS-CoV-2 tropism, although maternal HFD may not be a predisposing factor for COVID-19 in neonates.

In this study, we reported that chronic HFD feeding increased intestinal ACE2 protein expression, which may partly contribute to the higher susceptibility of individuals with obesity to COVID-19.

ACE2 was reported to be expressed in alveolar macrophages in the lung and CD169-positive macrophages in the spleen and lymph nodes, strengthening the evidence that SARS-CoV-2 can directly attack macrophages to trigger more severe symptoms (10, 14) . We also found that ACE2 is expressed in intestinal macrophages, consistent with a recent report that ACE2 is expressed in CD11b-enriched cells isolated from patients (15) . Furthermore, we also observed that ACE2 expression is undetectable in microglia. The latest research reported that SARS-CoV-2 can invade the central nervous system, infecting patients' neural progenitor cells and brain organoids (16) .

Thus, microglia in the brain might not be infected by viruses and may be able to execute their normal functions. This evidence suggests that the ACE2 expression levels in myeloid cells in various organs are differentially regulated.

It is of great significance to understand the maternal factors affecting the susceptibility of newborns to COVID-19 to prevent more newborns from being infected. In contrast to the results in adult DIO mice, the ACE2 protein levels were significantly decreased in the ileum of offspring exposed to maternal HFD. Thus, maternal HFD may not be a promoting factor for COVID-19 infection in the neonatal intestine and may even reduce susceptibility. However, contrary to recent studies in humans stating that intestinal Ace2 mRNA expression is increased with age (17, 18) and the lower disease severity in children group, we detected the highest protein levels of intestinal ACE2 in neonates compared with young (20-week-old) and old (56-week-old) adult mice. Ortiz et al also reported that ACE2 proteins are expressed on the cell surface of lung cells and higher in young children (19) . These conflict conclusions may be partly due to the inconsistence between mRNA and protein results of ACE2. We found that Ace2 mRNA results are not always the same as the western blot or immunohistochemical results. This discrepancy is more obvious in adult intestine in our study, indicating that in adult intestine ACE2 protein turnover rate might be slower. Thus, for ACE2, both protein and mRNA levels should be assessed before making conclusions.

This study provides some clues for COVID-19 susceptibility in people with metabolic diseases; however, due to biosafety requirements, intestinal ACE2 expression was analyzed in mice without SARS-CoV-2 infection. Whether patients with obesity exhibit more common gastrointestinal manifestations and higher intestinal viral loads requires additional clinical information.

Meanwhile, the role of ACE2 in intestinal macrophagesis still poorly understood. Further investigations may shed some light on these points. 

A novel coronavirus outbreak of global health concern

Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study

Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection

The endocrine and metabolic link between COVID-19, diabetes and obesity

Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19

Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Lipase Maintains Microglial Innate Immunity in Obesity

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients. medRxiv

The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD

SARS-CoV-2 infects human neural progenitor cells and brain organoids

SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age

Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS

Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract

Jia Sun 1 , Luo Chen 1 , Xiao-Ao Xiao 1 , Mo-Qiu Jia 1 , Xin-Yuan Wang 1 

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.